glp 1 released from GLP-1 is the small intestine after meal ingestion and GLP-1R Agonists for Weight Loss

Glutathione directly fights against free radicals and enables other antioxidants to do their job well, too

A healthy microbiome produces short-chain fatty acids like butyrate, which play a role in metabolic health

The risk of developing these severe side effects is very small, but it is important that patients and healthcare professionals are aware and alert to the associated symptoms. An estimated 1.6 million UK adults used GLP-1s such as semaglutide (Wegovy, Ozempic) and tirzepatide (Mounjaro) to lose weight between early 2024 and early 2025, with an additional 3.3 million interested in using weight loss drugs during 2026

Your choice should reflect your enrollment status in a high-deductible health plan (required for HSAs) and your anticipated GLP-1 therapy duration